Artificial Respiration (Mechanical Ventilation)

Subscribe to Selected New Research on Artificial Respiration

8558 relevant articles (297 outcomes, 640 trials/studies) found for this Therapy

Description: Any method of artifical breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2 ) and excretion of carbon dioxide (CO2 ).

Also Known As:

Mechanical Ventilation; Respiration, Artificial; Artificial Respirations; Mechanical Ventilations; Respirations, Artificial; Ventilations, Mechanical; Ventilation, Mechanical

Relationship Network

Therapy Context: Research Results

Therapeutics: 6127

Emergency Treatment: 1782

Resuscitation: 10859

Artificial Respiration: 8558

Respiratory Therapy: 502

Artificial Respiration: 8558

Positive-Pressure Respiration: 2768

High-Frequency Ventilation: 427

Liquid Ventilation: 253

Ventilator Weaning: 41

Experts

1.	Martin, Thomas R: 5 articles (06/2008 - 04/2003)
2.	Slutsky, Arthur S: 5 articles (05/2006 - 04/2003)
3.	Schönhofer, B: 4 articles (08/2008 - 04/2000)
4.	Plötz, Frans B: 4 articles (07/2008 - 05/2003)
5.	Schultz, Marcus J: 4 articles (04/2008 - 12/2005)
6.	Qin, Ying-zhi: 4 articles (02/2007 - 06/2003)
7.	Chevret, S: 4 articles (01/2007 - 01/2000)
8.	Gajic, Ognjen: 4 articles (01/2007 - 09/2004)
9.	Sharshar, Tarek: 4 articles (06/2004 - 01/2003)
10.	Sociedad Española de Cuidados Intensivos Pediátricos: 4 articles (10/2003 - 10/2003)

Related Diseases

1.	Respiratory Insufficiency (Respiratory Failure) 11/01/1994 - "The following conclusions are drawn from critical evaluation of the collected data: (1) Closed system positive pressure mechanical ventilation applied at mild to moderate levels of intensity is a safe and effective method for augmenting deficient blood gas exchange in most patients who are in acute respiratory failure. " 06/01/1997 - "Respiratory failure developed within 54 h and CO2 could not be eliminated, even by very invasive mechanical ventilation. " 12/01/2005 - "STUDY OBJECTIVE: Noninvasive mechanical ventilation (NIMV) is beneficial for patients with acute respiratory failure (ARF) when added to medical treatment. " 11/01/2008 - "BACKGROUND AND OBJECTIVES: Noninvasive home mechanical ventilation (HMV) has been shown to be beneficial for certain forms of respiratory failure, improving symptoms and quality of life. " 04/01/2003 - "CONCLUSION: The prone position may prove beneficial in some cases of hypoxemic respiratory failure, even in awake patients, by avoiding mechanical ventilation and ventilator-associated complications." Order ALL the reference details at left...
2.	Chronic Obstructive Pulmonary Disease (COPD) 05/07/1994 - "CONCLUSIONS: Back up pressure face mask is the technique of choice in patients with chronic obstructive pulmonary disease in acute decompensation given that this technique leads to a rapid and significant improvement of gaseous exchange and avoids the need for intubation and mechanical ventilation in most of these patients." 11/01/2009 - "RESULTS: There was a significant reduction (P = 0.013) in the period the patients with COPD spent on the mechanical ventilation when received intravenous supplementation (9.4 +/- 7.3 days) compared with the COPD patients who received placebo (17.8 +/- 7.6 days). " 07/15/2001 - "We designed a prospective multicenter randomized controlled study in three long-term weaning units (LWU) to evaluate which protocol, inspiratory pressure support ventilation (PSV) or spontaneous breathing trials (SB), is more effective in weaning patients with chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation for more than 15 d. " 11/01/1997 - "We conclude that chest wall mechanics are abnormal in chronic obstructive pulmonary disease patients with acute ventilatory failure undergoing controlled mechanical ventilation and that positive end-expiratory pressure does not seem to be effective in reducing either elastance or resistance of the lung or chest wall." 01/01/2007 - "Randomized controlled trials have confirmed the evidence and helped to define when and where non invasive mechanical ventilation (NIV) should be the first line treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD). " Order ALL the reference details at left...
3.	Critical Illness (Critically Ill) 08/01/2007 - "We evaluated the efficacy of the COMFORT scale in assessing optimal sedation in critically ill children requiring mechanical ventilation. " 08/01/2007 - "The efficacy of the COMFORT scale in assessing optimal sedation in critically ill children requiring mechanical ventilation." 10/01/2003 - "STUDY OBJECTIVES: To compare the diagnostic capability of recently available hand-held echocardiography (HHE) and of conventional transthoracic echocardiography (TTE) used as a gold standard in critically ill patients under mechanical ventilation. " 09/01/2009 - "CONCLUSIONS: Expedited admission (<2 hours) of critically ill patients requiring intubation and mechanical ventilation from the ED to the ICU was associated with shorter durations of mechanical ventilation and ICU length of stay, suggesting that prompt ICU admission results in improved use of resources." 06/01/2008 - "CONCLUSION: Newer modalities of sedation and mechanical ventilation have not entirely eliminated the discomforts of critical illness; the human aspects of suffering remain. " Order ALL the reference details at left...
4.	Pneumonia (Pneumonitis) 01/01/2006 - "There was a significant reduction in the incidence of nosocomial pneumonia (pooled odds ratio (OR) 0.38, 95% confidence interval (CI) 0.28 to 0.53), but no reduction in mortality (pooled OR 0.96, 95%CI 0.66 to 1.14), duration of mechanical ventilation (pooled standardized mean difference (SMD) -0.14 days, 95%CI, -0.29 to 0.02), duration of intensive care unit stay (pooled SMD -0.064 days, 95% CI, -0.21 to 0.086) or duration of hospital stay (pooled SMD 0.05 days, 95% CI -0.18 to 0.27). " 05/01/2005 - "Histologic examination showed increased recruitment of the dependent lung in groups 3 and 4, with significantly greater lung expansion index, than groups 1 and 2. CONCLUSIONS: PLV, with a single dose of higher viscosity and lower vapor pressure PFC, resulted in significantly improved gas exchange and lung mechanics with significant reduction in lung inflammation compared with conventional mechanical ventilation alone and PLV with lower viscosity and higher vapor pressure liquid. " 07/01/2004 - "CONCLUSIONS: Notable results were the greater requirement for mechanical ventilation in Legionella pneumonia and the good results obtained by home-based hospital care within current health care management." 08/01/2008 - "CONCLUSION: Systolic BP is superior to other haemodynamic predictors of 30 day mortality and need for mechanical ventilation and/or inotropic support in community acquired pneumonia. " 01/01/2004 - "These results suggest that PTXF may be effective in modulating lung inflammation associated with mechanical ventilation in neonates." Order ALL the reference details at left...
5.	Syndrome 01/01/2009 - "CONCLUSIONS: In premature infants treated with nasal continuous positive airway pressure early after birth, the addition of very early surfactant therapy without mandatory ventilation decreased the need for subsequent mechanical ventilation, decreased the incidence of air-leak syndrome, and seemed to be safe. " 08/01/2001 - "We investigated whether the combination of surfactant replacement therapy and early application of high-frequency oscillatory ventilation (HFOV) was more effective in patients with respiratory distress syndrome (RDS) than late application of HFOV and conventional mechanical ventilation (CMV). " 08/25/1988 - "We conclude that significant improvement in pulmonary mechanics results from surfactant-replacement therapy for respiratory distress syndrome, but that these mechanical changes are apparent only during spontaneous respiration and can be masked if measurements are made during mechanical ventilation." 04/01/1984 - "Measurements of body water homeostasis and pulmonary function were obtained in 24 infants with respiratory distress syndrome requiring mechanical ventilation during the first five days of life to determine the relationship of diuresis to improvement in pulmonary function. " 07/01/1982 - "To evaluate the relationship between improvement in pulmonary function and spontaneous diuresis in respiratory distress syndrome, nine premature infants requiring mechanical ventilation for RDS were studied at a mean age of 11.9 hours prior to the onset of diuresis, at onset of diuresis, at maximum urine output (mean age 44.9 hours), and at 24 hours after maximum urine output. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Oxygen
2.	Ketamine
3.	Carbon Dioxide
4.	Adrenal Cortex Hormones (Corticosteroids)
5.	Midazolam (Versed)
6.	Creatinine
7.	Anti-Bacterial Agents (Antibiotics)
8.	Bronchodilator Agents (Bronchodilators)
9.	Epinephrine (Adrenaline)
10.	Halothane (Fluothane)

Related Therapies and Procedures

1.	Positive-Pressure Respiration (PEEP)
2.	Length of Stay
3.	Mechanical Ventilators (Ventilator)
4.	Intensive Care (Surgical Intensive Care)
5.	Continuous Positive Airway Pressure

Best Treatments:
Research Summary Report
on Respiratory Insufficiency

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 505 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>